Serum RBP4 positively correlates with triglyceride level but not with BMI, fat mass and insulin resistance in healthy obese and non-obese individuals

References

• American Diabetes Association, 2015. Classification and diagnosis of diabetes. Sec. 2. In Standards of Medical Care in Diabetes – 2015. Diabetes care, 38 (Supplement_1), S8–S 16.
   Web of Science ®Google Scholar
• Balistreri, C.R., Caruso, C., and Candore, G., 2010. The role of adipose tissue and adipokines in obesity-related inflammatory diseases. Mediators of inflammation, 2010, 1.
   Google Scholar
• Biden, T.J., et al., 2004. Chronic effects of fatty acids on pancreatic beta-cell function: new insights from functional genomics. Diabetes, 53 (Supplement 1), S159–S165.
   PubMedGoogle Scholar
• Blaner, W.S., 1989. Retinol-binding protein: the serum transport protein for vitamin A. Endocrine reviews, 10 (3), 308–316.
   PubMed Web of Science ®Google Scholar
• Broch, M. et al, 2007. Circulating retinol-binding protein-4, insulin sensitivity, insulin secretion, and insulin disposition index in obese and nonobese subjects. subjects. Diabetes care, 30 (7), 1802–1806.
   PubMed Web of Science ®Google Scholar
• Chiba, M., et al., 2010. Associations of metabolic factors, especially serum retinol-binding protein 4 (RBP4), with blood pressure in Japanese – the Tanno and Sobetsu study. Endocrine journal, 57 (9), 811–817.
   PubMed Web of Science ®Google Scholar
• Erikstrup, C., Mortensen, O.H., and Pedersen, B.K., 2006. Retinol-binding protein 4 and insulin resistance. The new England journal of medicine, 355 (13), 1393–1394.
   PubMed Web of Science ®Google Scholar
• Gavi, S., et al., 2007. Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 diabetes. The journal of clinical endocrinology and metabolism, 92 (5), 1886–1890.
   PubMed Web of Science ®Google Scholar
• Graham, T.E., et al., 2006. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. The new England journal of medicine, 354 (24), 2552–2563.
   PubMed Web of Science ®Google Scholar
• Haider, D.G., et al., 2007. Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. The journal of clinical endocrinology and metabolism, 92 (3), 1168–1171.
   PubMed Web of Science ®Google Scholar
• Inadera, H., 2008. The usefulness of circulating adipokine levels for the assessment of obesity-related health problems. International journal of medical sciences, 5 (5), 248–262.
   PubMedGoogle Scholar
• Janke, J., et al., 2006. Retinol-binding protein 4 in human obesity. Diabetes, 55 (10), 2805–2810.
   PubMed Web of Science ®Google Scholar
• Jung, U.J., and Choi, M.S., 2014. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. International journal of molecular sciences, 15 (4), 6184–6223.
   PubMed Web of Science ®Google Scholar
• Junjun, W., et al., 2013. Associations of RBP4 with lipid metabolism and renal function in diabetes mellitus. European journal of lipid science and technology, 115 (8), 831–837.
   Web of Science ®Google Scholar
• Kotnik, P., Fischer-Posovszky, P., and Wabitsch, M., 2011. RBP4: a controversial adipokine. European journal of endocrinology, 165 (5), 703–711.
   PubMed Web of Science ®Google Scholar
• Kwon, H., and Pessin, J.E., 2013. Adipokines mediate inflammation and insulin resistance. Frontiers in endocrinology, 4, 71.
   PubMedGoogle Scholar
• Liu, Y., et al., 2016. Retinol-binding protein 4 induces hepatic mitochondrial dysfunction and promotes hepatic steatosis. The journal of clinical endocrinology and metabolism, 101 (11), 4338–4348.
   PubMed Web of Science ®Google Scholar
• Mallat, Z., et al., 2009. Retinol-binding protein 4 and prediction of incident coronary events in healthy men and women. The journal of clinical endocrinology and metabolism, 94 (1), 255–260.
   PubMed Web of Science ®Google Scholar
• National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), 2002. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation, 106 (25), 3143–3421.
   PubMed Web of Science ®Google Scholar
• Perseghin, G., et al., 2007. Serum retinol-binding protein-4, leptin, and adiponectin concentrations are related to ectopic fat accumulation. The journal of clinical endocrinology and metabolism, 92 (12), 4883–4888.
   PubMed Web of Science ®Google Scholar
• Quadro, L., et al., 1999. Impaired retinal function and vitamin A availability in mice lacking retinol-binding protein. The EMBO journal, 18 (17), 4633–4644.
   PubMed Web of Science ®Google Scholar
• Rabe, K., et al., 2008. Adipokines and insulin resistance. Molecular medicine (Cambridge, mass), 14 (11–12), 741–751.
   PubMed Web of Science ®Google Scholar
• Rocha, M., et al., 2013. Association of serum retinol binding protein 4 with atherogenic dyslipidemia in morbid obese patients. PLoS One, 8 (11), e78670.
   PubMed Web of Science ®Google Scholar
• Takashima, N., Tomoike, H., and Iwai, N., 2006. Retinol-binding protein 4 and insulin resistance. New England journal of medicine, 355 (13), 1392.
   PubMedGoogle Scholar
• Trayhurn, P., and Wood, I.S., 2005. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochemical society transactions, 33 (Pt 5), 1078–1081.
   PubMedGoogle Scholar
• Vergès, B., et al., 2012. Retinol-binding protein 4 is an independent factor associated with triglycerides and a determinant of very low-density lipoprotein-apolipoprotein B100 catabolism in type 2 diabetes mellitus. Arteriosclerosis, thrombosis, and vascular biology, 32 (12), 3050–3057.
   PubMed Web of Science ®Google Scholar
• Wang, M.N., et al., 2012. Higher serum retinol binding protein 4 may be a predictor of weak metabolic control in chinese patients with type 2 diabetes mellitus. Journal of international medical research, 40 (4), 1317–1324.
   PubMed Web of Science ®Google Scholar
• Weir, G.C., et al., 2001. Beta-cell adaptation and decompensation during the progression of diabetes. Diabetes, 50 (Supplement 1), S154–S159.
   PubMedGoogle Scholar
• World Health Organization, 2009. Global Database on Body Mass Index: BMI Classification [online]. Available from: http://apps.who.int/bmi/index.jsp?introPage=intro_3.html [Accessed 20 October 2016].
   Google Scholar
• Xia, M., et al., 2013. Retinol binding protein 4 stimulates hepatic sterol regulatory element-binding protein 1 and increases lipogenesis through the peroxisome proliferator-activated receptor-γ coactivator 1β-dependent pathway. Hepatology, 58 (2), 564–575.
   PubMed Web of Science ®Google Scholar
• Yagmur, E., et al., 2007. Elevated apoptosis-associated cytokeratin 18 fragments (CK18Asp386) in serum of patients with chronic liver diseases indicate hepatic and biliary inflammation. Clinical biochemistry, 40 (9–10), 651–655.
   PubMed Web of Science ®Google Scholar
• Yang, Q., et al., 2005. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature, 436 (7049), 356–362.
   PubMed Web of Science ®Google Scholar